Adriana Albini

Q: What Schools Are Affiliated With Adriana Albini

Adriana Albini is affiliated with the following schools: University of Milan, University of Genoa, University of Milano-Bicocca, University of Turin

Adriana Albini's AcademicInfluence.com Rankings

Adriana Albini

Law

#2325

World Rank

#2900

Historical Rank

Common Law

#84

World Rank

#92

Historical Rank

law Degrees

Adriana Albini

Philosophy

#6048

World Rank

#9012

Historical Rank

Logic

#3239

World Rank

#4366

Historical Rank

philosophy Degrees

Download Badge

Law
Philosophy

Adriana Albini's Degrees

PhD Biomedical Sciences University of Milan
Doctorate Medicine University of Milan

Why Is Adriana Albini Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Adriana Albini is an Italian pathologist and cancer researcher. She developed the concept of angioprevention which can be used to control cancer development. She is a competitive fencer and six of her novels have been published. In 2000 she was the Scientific Director at the Fondazione MultiMedica Onlus in Milan.

(See a Problem?)

Adriana Albini's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

A rapid in vitro assay for quantitating the invasive potential of tumor cells. (1987) (1904)
The tumour microenvironment as a target for chemoprevention (2007) (792)
Cardiotoxicity of Anticancer Drugs: The Need for Cardio-Oncology and Cardio-Oncological Prevention (2010) (690)
Bone marrow neovascularization, plasma cell angiogenic potential, and matrix metalloproteinase-2 secretion parallel progression of human multiple myeloma. (1999) (649)
The angiogenesis induced by HIV–1 Tat protein is mediated by the Flk–1/KDR receptor on vascular endothelial cells (1996) (417)
Tumor cell invasion inhibited by TIMP-2. (1991) (341)
Neutrophil Restraint by Green Tea: Inhibition of Inflammation, Associated Angiogenesis, and Pulmonary Fibrosis1 (2003) (337)
Tumor gelatinases and invasion inhibited by the green tea flavanol epigallocatechin‐3‐gallate (2001) (329)
‘Angioprevention’: angiogenesis is a common and key target for cancer chemopreventive agents (2002) (328)
HIV-1 Tat protein mimicry of chemokines. (1998) (304)
c-fos-induced growth factor/vascular endothelial growth factor D induces angiogenesis in vivo and in vitro. (1999) (295)
Tumors and inflammatory infiltrates: Friends or foes? (2004) (276)
Cancer prevention by targeting angiogenesis (2012) (266)
Contribution to Tumor Angiogenesis From Innate Immune Cells Within the Tumor Microenvironment: Implications for Immunotherapy (2018) (263)
The α3β1 integrin is associated with mammary carcinoma cell metastasis, invasion, and gelatinase B (mmp‐9) activity (2000) (251)
Inflammation, inflammatory cells and angiogenesis: decisions and indecisions (2008) (250)
CXCL1/Macrophage Inflammatory Protein-2-Induced Angiogenesis In Vivo Is Mediated by Neutrophil-Derived Vascular Endothelial Growth Factor-A1 (2004) (234)
Angiogenic properties of human immunodeficiency virus type 1 Tat protein. (1995) (227)
TIMP‐2 over‐expression reduces invasion and angiogenesis and protects B16F10 melanoma cells from apoptosis (1998) (221)
Inhibition of angiogenesis in vivo and growth of Kaposi's sarcoma xenograft tumors by the anti-malarial artesunate. (2004) (218)
The Chemopreventive Polyphenol Curcumin Prevents Hematogenous Breast Cancer Metastases in Immunodeficient Mice (2006) (209)
Effects of 5-Fluorouracil on Morphology, Cell Cycle, Proliferation, Apoptosis, Autophagy and ROS Production in Endothelial Cells and Cardiomyocytes (2015) (205)
Neutrophils as a key cellular target for angiostatin: implications for regulation of angiogenesis and inflammation (2002) (196)
Vascular endothelial growth factor regulates angiogenesis and vascular permeability in Kaposi's sarcoma. (1996) (196)
Interaction of HIV-1 Tat Protein with Heparin (1997) (194)
The HtrA1 serine protease is down-regulated during human melanoma progression and represses growth of metastatic melanoma cells (2002) (194)
Mechanisms of Inhibition of Tumor Angiogenesis and Vascular Tumor Growth by Epigallocatechin-3-Gallate (2004) (192)
Tumor inflammatory angiogenesis and its chemoprevention. (2005) (191)
The chemoinvasion assay: a method to assess tumor and endothelial cell invasion and its modulation (2007) (190)
The proangiogenic phenotype of natural killer cells in patients with non-small cell lung cancer. (2013) (189)
Tumor invasion: molecular shears blunted by green tea (1999) (178)
Tumor and endothelial cell invasion of basement membranes. The matrigel chemoinvasion assay as a tool for dissecting molecular mechanisms. (1998) (176)
HIV-tat protein is a heparin-binding angiogenic growth factor. (1996) (175)
Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi’s sarcoma (2012) (175)
Mechanisms of the antiangiogenic activity by the hop flavonoid xanthohumol: NF‐κB and Akt as targets (2006) (173)
Phenotypic and functional analysis of T cells homing into the CSF of subjects with inflammatory diseases of the CNS (2003) (172)
Somatostatin inhibits tumor angiogenesis and growth via somatostatin receptor-3-mediated regulation of endothelial nitric oxide synthase and mitogen-activated protein kinase activities. (2003) (168)
The alpha 3 beta 1 integrin is associated with mammary carcinoma cell metastasis, invasion, and gelatinase B (MMP-9) activity. (2000) (160)
Angiogenic potential in vivo by Kaposi's sarcoma cell-free supernatants and HIV-1 tat product: inhibition of KS-like lesions by tissue inhibitor of metalloproteinase-2 (1994) (160)
Identification of Genes Selectively Regulated by IFNs in Endothelial Cells1 (2007) (158)
A Think Tank of TINK/TANKs: Tumor-Infiltrating/Tumor-Associated Natural Killer Cells in Tumor Progression and Angiogenesis (2014) (158)
Tissue inhibitors of metalloproteases: Regulation and biological activities (2004) (155)
The guanylate binding protein‐1 GTPase controls the invasive and angiogenic capability of endothelial cells through inhibition of MMP‐1 expression (2003) (155)
Polyphenolic antioxidant (-)-epigallocatechin-3-gallate from green tea as a candidate anti-HIV agent. (2002) (151)
Microalgal Derivatives as Potential Nutraceutical and Food Supplements for Human Health: A Focus on Cancer Prevention and Interception (2019) (142)
Vascular Endothelial Growth Factor Receptor-1 Contributes to Resistance to Anti–Epidermal Growth Factor Receptor Drugs in Human Cancer Cells (2008) (141)
Nutrigenomics of extra‐virgin olive oil: A review (2017) (141)
Generation of Biologically Active Angiostatin Kringle 1–3 by Activated Human Neutrophils1 (2002) (140)
Identification of a Novel Domain of HIV Tat Involved in Monocyte Chemotaxis* (1998) (134)
Chemopreventive properties and mechanisms of N‐acetylcysteine. The experimental background (1995) (134)
Inhibition of angiogenesis and vascular tumor growth by interferon-producing cells: A gene therapy approach. (2000) (133)
Bcl‐2 overexpression and hypoxia synergistically act to modulate vascular endothelial growth factor expression and in vivo angiogenesis in a breast carcinoma line (2000) (131)
HIV-1 Tat causes apoptotic death and calcium homeostasis alterations in rat neurons. (2001) (131)
Somatostatin controls Kaposi's sarcoma tumor growth through inhibition of angiogenesis (1999) (129)
Transferrin Promotes Endothelial Cell Migration and Invasion: Implication in Cartilage Neovascularization (1997) (129)
Paradoxic effects of metformin on endothelial cells and angiogenesis (2014) (127)
The tumor microenvironment of colorectal cancer: stromal TLR-4 expression as a potential prognostic marker (2010) (127)
Differential regulation of growth and invasiveness of MCF-7 breast cancer cells by antiestrogens. (1988) (124)
Inhibition of invasion, gelatinase activity, tumor take and metastasis of malignant cells by N‐acetylcysteine (1995) (123)
Antiangiogenic Activity of the MDM2 Antagonist Nutlin-3 (2007) (122)
Multiple points of intervention in the prevention of cancer and other mutation-related diseases. (2001) (122)
Cancer stem cells and the tumor microenvironment: interplay in tumor heterogeneity (2015) (120)
The β‐core fragment of human chorionic gonadotrophin inhibits growth of Kaposi's sarcoma‐derived cells and a new immortalized Kaposi's sarcoma cell line (1997) (120)
17 beta-estradiol regulates and v-Ha-ras transfection constitutively enhances MCF7 breast cancer cell interactions with basement membrane. (1986) (120)
Anti-Invasive Effects of Green Tea Polyphenol EpiGalloCatechin-3-Gallate (EGCG), a Natural Inhibitor of Metallo and Serine Proteases (2002) (119)
The biguanides metformin and phenformin inhibit angiogenesis, local and metastatic growth of breast cancer by targeting both neoplastic and microenvironment cells (2015) (119)
The α3β1 Integrin Is Involved in Melanoma Cell Migration and Invasion (1995) (118)
Microarray expression profiles of angiogenesis-related genes predict tumor cell response to artemisinins (2006) (118)
α-Lipoic acid is effective in prevention and treatment of experimental autoimmune encephalomyelitis (2004) (115)
Myeloid Derived Suppressor Cells Interactions With Natural Killer Cells and Pro-angiogenic Activities: Roles in Tumor Progression (2019) (114)
N-acetylcysteine inhibits endothelial cell invasion and angiogenesis. (1999) (113)
Cytokines and chemokines as regulators of angiogenesis in health and disease. (2006) (112)
HIV Tat, its TARgets and the control of viral gene expression. (2003) (110)
The SARS-CoV-2 receptor, ACE-2, is expressed on many different cell types: implications for ACE-inhibitor- and angiotensin II receptor blocker-based cardiovascular therapies (2020) (108)
Cannabidiol inhibits angiogenesis by multiple mechanisms (2012) (106)
COVID-19 and Obesity: Dangerous Liaisons (2020) (105)
Inhibition of angiogenesis-driven Kaposi's sarcoma tumor growth in nude mice by oral N-acetylcysteine. (2001) (100)
Modulation of invasive properties of murine squamous carcinoma cells by heterologous expression of cathepsin B and cystatin C (1999) (98)
Angiogenesis and cancer prevention: a vision. (2007) (98)
HIV-1-Tat Protein Activates Phosphatidylinositol 3-Kinase/ AKT-dependent Survival Pathways in Kaposi's Sarcoma Cells* (2002) (98)
The "chemoinvasion assay": a tool to study tumor and endothelial cell invasion of basement membranes. (2004) (97)
TIMP‐2, Over‐expression reduces invasion and angiogenesis and protects B16F10 melanoma cells from apoptosis. Int. J. Cancer 75, 246–253 (1998) (1999) (96)
Orchestration of Angiogenesis by Immune Cells (2014) (96)
Classification of pulmonary neuroendocrine tumors: new insights. (2017) (96)
Vascular Endothelial Growth Factor-C Stimulates the Migration and Proliferation of Kaposi’s Sarcoma Cells* (1999) (95)
Inhibition of tumor cell invasion by a highly conserved peptide sequence from the matrix metalloproteinase enzyme prosegment. (1992) (95)
Expression of beta 1B integrin isoform in CHO cells results in a dominant negative effect on cell adhesion and motility (1994) (94)
The Role of the Thiol N-Acetylcysteine in the Prevention of Tumor Invasion and Angiogenesis (1999) (92)
Latent BK virus infection and Kaposi's sarcoma pathogenesis (1996) (90)
Role of soluble mediators in angiogenesis. (1996) (88)
Invasive phenotype of MCF10A cells overexpressing c‐Ha‐ras and c‐erbB‐2 oncogenes (1995) (85)
Differential effects of angiostatin, endostatin and interferon-α1 gene transfer on in vivo growth of human breast cancer cells (2002) (83)
Inhibition of CXCR4-dependent HIV-1 infection by extracellular HIV-1 Tat. (2000) (83)
Green tea polyphenol epigallocatechin-3-gallate inhibits the endothelin axis and downstream signaling pathways in ovarian carcinoma (2006) (81)
Metastasis signatures: genes regulating tumor–microenvironment interactions predict metastatic behavior (2007) (80)
AKT/NF‐κB inhibitor xanthohumol targets cell growth and angiogenesis in hematologic malignancies (2007) (79)
Role of the α3β1 and α6β4 integrins in tumor invasion (2004) (79)
The Combined Action of IL-15 and IL-12 Gene Transfer Can Induce Tumor Cell Rejection Without T and NK Cell Involvement1 (2000) (78)
From the outside in: extracellular activities of HIV Tat. (2000) (78)
The Transforming Growth Factor-β Family Members Bone Morphogenetic Protein-2 and Macrophage Inhibitory Cytokine-1 as Mediators of the Antiangiogenic Activity of N-(4-Hydroxyphenyl)Retinamide (2005) (77)
Interactions of single-wall carbon nanotubes with endothelial cells. (2010) (76)
Antileukemia effects of xanthohumol in Bcr/Abl-transformed cells involve nuclear factor-κB and p53 modulation (2008) (75)
Human immunodeficiency virus transactivator protein (Tat) stimulates chemotaxis, calcium mobilization, and activation of human polymorphonuclear leukocytes: implications for Tat-mediated pathogenesis. (2000) (74)
KSHV sequences in biopsies and cultured spindle cells of epidemic, iatrogenic and Mediterranean forms of Kaposi's sarcoma. (1996) (74)
In Vitro Models of Angiogenesis: The use of Matrigel (1999) (73)
The 'chemoinvasion' assay, 25 years and still going strong: the use of reconstituted basement membranes to study cell invasion and angiogenesis. (2010) (72)
Angiogenin and the MMP9‐TIMP2 axis are up‐regulated in proangiogenic, decidual NK‐like cells from patients with colorectal cancer (2018) (72)
Collagenolytic cleavage products of collagen type I as chemoattractants for human dermal fibroblasts. (1985) (71)
Metabolic regulation and redox activity as mechanisms for angioprevention by dietary phytochemicals (2009) (69)
Reference Profile Correlation Reveals Estrogen-like Trancriptional Activity of Curcumin (2010) (69)
Anti-angiogenesis and angioprevention: mechanisms, problems and perspectives. (2003) (68)
Enhanced chemotaxis of tumor‐derived and virus‐transformed cells to fibronectin and fibroblast‐conditioned medium (1984) (67)
Suppression of invasive behavior of melanoma cells by stable expression of anti-sense perlecan cDNA. (1997) (66)
Prevention and Treatment of Experimental Estrogen Receptor – Negative Mammary Carcinogenesis by the Synthetic Triterpenoid CDDO-Methyl Ester and the Rexinoid LG100268 (2008) (66)
New N-arylsulfonyl-N-alkoxyaminoacetohydroxamic acids as selective inhibitors of gelatinase A (MMP-2). (2004) (65)
Antiangiogenic and Antitumor Effects of Trypanosoma cruzi Calreticulin (2010) (64)
A Mouse Model of Pulmonary Metastasis from Spontaneous Osteosarcoma Monitored In Vivo by Luciferase Imaging (2008) (63)
Chemotaxis of 3T3 and SV3T3 cells to fibronectin is mediated through the cell-attachment site in fibronectin and a fibronectin cell surface receptor (1987) (62)
Monocyte‐derived dendritic cells and monocytes migrate to HIV‐Tat RGD and basic peptides (1998) (62)
A Single Cis-acting Element in a Short Promoter Segment of the Gene Encoding the Interphotoreceptor Retinoid-binding Protein Confers Tissue-specific Expression (*) (1995) (62)
Anti-FGF2 approaches as a strategy to compensate resistance to anti-VEGF therapy: long-pentraxin 3 as a novel antiangiogenic FGF2-antagonist. (2009) (62)
Synergism between N‐acetylcysteine and doxorubicin in the prevention of tumorigenicity and metastasis in murine models (1996) (62)
AAV-mediated gene transfer of tissue inhibitor of metalloproteinases-1 inhibits vascular tumor growth and angiogenesis in vivo (2004) (61)
TRAIL inhibits angiogenesis stimulated by VEGF expression in human glioblastoma cells (2006) (61)
Osteoblastic cells from rat long bone. I. Characterization of their differentiation in culture. (1995) (60)
Alpha-lipoic acid is effective in prevention and treatment of experimental autoimmune encephalomyelitis. (2004) (60)
Supernatants of acquired immunodeficiency syndrome-related Kaposi's sarcoma cells induce endothelial cell chemotaxis and invasiveness. (1991) (60)
Osteoblasts modulate secretion of urokinase-type plasminogen activator (uPA) and matrix metalloproteinase-9 (MMP-9) in human prostate cancer cells promoting migration and matrigel invasion. (1999) (59)
In vitro regulation of pericellular proteolysis in prostatic tumor cells treated with bombesin (1998) (58)
Neutrophils and angiogenesis: potential initiators of the angiogenic cascade. (2003) (58)
The Akt inhibitor deguelin, is an angiopreventive agent also acting on the NF-kappaB pathway. (2006) (56)
The synthetic oleanane triterpenoid, CDDO-methyl ester, is a potent antiangiogenic agent (2007) (55)
Most high-grade neuroendocrine tumours of the lung are likely to secondarily develop from pre-existing carcinoids: innovative findings skipping the current pathogenesis paradigm (2018) (54)
Endothelin receptor blockade inhibits molecular effectors of Kaposi's sarcoma cell invasion and tumor growth in vivo. (2003) (54)
Molecular Pathways for Cancer Angioprevention (2007) (54)
Prostate carcinoma and green tea: (−)epigallocatechin‐3‐gallate inhibits inflammation‐triggered MMP‐2 activation and invasion in murine TRAMP model (2004) (52)
Thrombospondin‐1 inhibits Kaposi's sarcoma (KS) cell and HIV‐1 Tat‐induced angiogenesis and is poorly expressed in KS lesions (1999) (52)
Inhibition by oral N-acetylcysteine of doxorubicin-induced clastogenicity and alopecia, and prevention of primary tumors and lung micrometastases in mice. (1998) (52)
TGFbeta1 antagonistic peptides inhibit TGFbeta1-dependent angiogenesis. (2009) (51)
Osteoblast‐derived TGFβ‐1 modulates matrix degrading protease expression and activity in prostate cancer cells (2000) (51)
Cancer chemoprevention revisited: Cytochrome P450 family 1B1 as a target in the tumor and the microenvironment. (2018) (50)
Inhibition of AIDS-Kaposi's sarcoma cell induced endothelial cell invasion by TIMP-2 and a synthetic peptide from the metalloproteinase propeptide: implications for an anti-angiogenic therapy. (1994) (50)
DNA damage in liver, kidney, bone marrow, and spleen of rats and mice treated with commercial and purified aniline as determined by alkaline elution assay and sister chromatid exchange induction. (1982) (49)
Production of angiogenesis inhibitors and stimulators is modulated by cultured growth plate chondrocytes during in vitro differentiation: dependence on extracellular matrix assembly. (1995) (48)
Growth factor supplemented matrigel improves ectopic skeletal muscle formation—a cell therapy approach (2001) (48)
Cancer Prevention and Interception: A New Era for Chemopreventive Approaches (2016) (47)
Activation of CD40 favors the growth and vascularization of Kaposi's sarcoma. (1999) (47)
Increased invasive, chemotactic and locomotive abilities of c-Ha-ras-transformed human breast epithelial cells. (1991) (47)
Aspirin and atenolol enhance metformin activity against breast cancer by targeting both neoplastic and microenvironment cells (2016) (46)
Cell density-dependent regulation of matrix metalloproteinase and TIMP expression in differently tumorigenic breast cancer cell lines. (2005) (46)
WT1 expression in angiogenic tumours of the skin (2005) (46)
Promotion of tumour metastases and induction of angiogenesis by native HIV‐1 Tat protein from BK virus/tat transgenic mice (1996) (46)
Growth factors and chemokines: a comparative functional approach between invertebrates and vertebrates. (2006) (45)
Angiostatin anti-angiogenesis requires IL-12: The innate immune system as a key target (2009) (45)
Matrigel promotes retinoblastoma cell growth in vitro and in vivo (1992) (44)
Inhibition of Kaposi's sarcoma in vivo by fenretinide. (2003) (44)
Hyperforin Blocks Neutrophil Activation of Matrix Metalloproteinase-9, Motility and Recruitment, and Restrains Inflammation-Triggered Angiogenesis and Lung Fibrosis (2007) (44)
N-(4-hydroxyphenyl)retinamide inhibits retinoblastoma growth through reactive oxygen species-mediated cell death. (2003) (44)
The alpha 3 beta 1 integrin is involved in melanoma cell migration and invasion. (1995) (42)
Validation of proposed prostate cancer biomarkers with gene expression data: a long road to travel (2014) (42)
N-O-Isopropyl Sulfonamido-Based Hydroxamates as Matrix Metalloproteinase Inhibitors: Hit Selection and in Vivo Antiangiogenic Activity. (2015) (41)
Prevention of angiogenesis by naked DNA IL-12 gene transfer: angioprevention by immunogene therapy (2004) (41)
Endothelin receptor blockade inhibits proliferation of Kaposi's sarcoma cells. (2001) (40)
Marine sponge-derived polymeric alkylpyridinium salts as a novel tumor chemotherapeutic targeting the cholinergic system in lung tumors. (2006) (40)
Proteinase‐3 directly activates MMP‐2 and degrades gelatin and Matrigel; differential inhibition by (−)epigallocatechin‐3‐gallate (2003) (40)
Exogenous hormonal regulation in breast cancer cells by phytoestrogens and endocrine disruptors. (2014) (40)
Decline of fibroblast chemotaxis with age of donor and cell passage number. (1988) (39)
Platforms and networks in triterpenoid pharmacology (2007) (39)
Insights into phenolic compounds from microalgae: structural variety and complex beneficial activities from health to nutraceutics (2021) (39)
Expression of CD44v3 protein in human endothelial cells in vitro and in tumoral microvessels in vivo. (2004) (39)
Cardio-oncology in targeting the HER receptor family: the puzzle of different cardiotoxicities of HER2 inhibitors. (2011) (39)
Angioprevention with fenretinide: targeting angiogenesis in prevention and therapeutic strategies. (2010) (38)
Systemic sclerosis-endothelial cell antiangiogenic pentraxin 3 and matrix metalloprotease 12 control human breast cancer tumor vascularization and development in mice. (2009) (38)
Kaposi's sarcoma cells of different etiologic origins respond to HIV-Tat through the Flk-1/KDR (VEGFR-2): relevance in AIDS-KS pathology. (2000) (38)
Highly stable oligomerization forms of HIV‐1 Tat detected by monoclonal antibodies and requirement of monomeric forms for the transactivating function on the HIV‐1 LTR (2000) (38)
Glycogen synthase kinase 3beta regulates cell death induced by synthetic triterpenoids. (2008) (38)
Over‐expression of hepatocyte growth factor in human Kaposi's sarcoma (1996) (38)
Natural Killer Cells from Malignant Pleural Effusion Are Endowed with a Decidual-Like Proangiogenic Polarization (2018) (37)
Marine Algal Antioxidants as Potential Vectors for Controlling Viral Diseases (2020) (37)
HIV type 1 Tat protein is a survival factor for Kaposi's sarcoma and endothelial cells. (2001) (37)
Mechanisms of Hyperforin as an anti-angiogenic angioprevention agent. (2009) (37)
Prostate Cancer Peripheral Blood NK Cells Show Enhanced CD9, CD49a, CXCR4, CXCL8, MMP-9 Production and Secrete Monocyte-Recruiting and Polarizing Factors (2020) (37)
Drink your prevention: beverages with cancer preventive phytochemicals. (2014) (37)
Inflammatory angiogenesis and the tumor microenvironment as targets for cancer therapy and prevention. (2014) (36)
Motility induced by human immunodeficiency virus-1 Tat on Kaposi's sarcoma cells requires platelet-activating factor synthesis. (1999) (35)
beta Interferon inhibits HIV-1 Tat-induced angiogenesis: synergism with 13-cis retinoic acid. (1998) (35)
Potential chemopreventive activities of a polyphenol rich purified extract from olive mill wastewater on colon cancer cells (2016) (35)
Inhibition of tumor angiogenesis by angiostatin: from recombinant protein to gene therapy. (2002) (35)
Oxytocin is a growth factor for Kaposi's sarcoma cells: evidence of endocrine-immunological cross-talk. (2002) (35)
Strategies to Prevent “Bad Luck” in Cancer (2015) (34)
Antiangiogenic activity of chemopreventive drugs. (2003) (34)
Antiapoptotic and antigenotoxic effects of N-acetylcysteine in human cells of endothelial origin. (2000) (34)
Molecular mechanisms of action of angiopreventive anti-oxidants on endothelial cells: microarray gene expression analyses. (2005) (33)
Diet-derived phytochemicals: from cancer chemoprevention to cardio-oncological prevention. (2011) (33)
Systemic distribution of single-walled carbon nanotubes in a novel model: alteration of biochemical parameters, metabolic functions, liver accumulation, and inflammation in vivo (2016) (32)
Prostate cancer and the invasive phenotype: application of new in vivo and in vitro approaches (1988) (32)
N-i-Propoxy-N-biphenylsulfonylaminobutylhydroxamic acids as potent and selective inhibitors of MMP-2 and MT1-MMP. (2005) (32)
Biological assays and genomic analysis reveal lipoic acid modulation of endothelial cell behavior and gene expression. (2006) (32)
Therapeutic potential of the metabolic modulator phenformin in targeting the stem cell compartment in melanoma (2016) (32)
Antitumor Effect of Green Tea Polyphenol Epigallocatechin-3-Gallate in Ovarian Carcinoma Cells: Evidence for the Endothelin-1 as a Potential Target (2006) (32)
Establishment and characterization of two new Kaposi's sarcoma cell cultures from an AIDS and a non-AIDS patient. (1994) (31)
Downregulation of Pro-Inflammatory and Pro-Angiogenic Pathways in Prostate Cancer Cells by a Polyphenol-Rich Extract from Olive Mill Wastewater (2019) (31)
Prediction of breast cancer metastasis by genomic profiling: where do we stand? (2009) (31)
Environmental impact of multi-wall carbon nanotubes in a novel model of exposure: systemic distribution, macrophage accumulation, and amyloid deposition (2015) (31)
HIV-Tat dependent chemotaxis and invasion, key aspects of Tat mediated pathogenesis (2004) (30)
An integrin-binding N-terminal peptide region of TIMP-2 retains potent angio-inhibitory and anti-tumorigenic activity in vivo (2011) (30)
Laminin-induced retinoblastoma cell differentiation: possible involvement of a 100-kDa cell-surface laminin-binding protein. (1992) (30)
Recent advances in the molecular landscape of lung neuroendocrine tumors (2019) (30)
Acetyl-L-Carnitine downregulates invasion (CXCR4/CXCL12, MMP-9) and angiogenesis (VEGF, CXCL8) pathways in prostate cancer cells: rationale for prevention and interception strategies (2019) (30)
Oncostatin M activates phosphatidylinositol-3-kinase in Kaposi's sarcoma cells. (1994) (30)
Thymus neuroendocrine tumors with CTNNB1 gene mutations, disarrayed ß-catenin expression, and dual intra-tumor Ki-67 labeling index compartmentalization challenge the concept of secondary high-grade neuroendocrine tumor: a paradigm shift (2017) (29)
Localization of the chemotactic domain in fibronectin (1983) (28)
Role of the alpha3beta1 and alpha6beta4 integrins in tumor invasion. (2002) (27)
Effects of angiostatin gene transfer on functional properties and in vivo growth of Kaposi's sarcoma cells. (2001) (27)
Oncogenesis in HIV-infection. (1996) (27)
Synthesis and antiangiogenic activity study of new hop chalcone Xanthohumol analogues. (2017) (27)
Propagation and properties of Kaposi's sarcoma-derived cell lines obtained from patients with AIDS: similarity of cultured cells to smooth muscle cells. (1991) (26)
Endocrine disruptor agent nonyl phenol exerts an estrogen-like transcriptional activity on estrogen receptor positive breast cancer cells. (2014) (26)
Endothelial cell aging and apoptosis in prevention and disease: E-selectin expression and modulation as a model. (2008) (26)
Hop derived flavonoid xanthohumol inhibits endothelial cell functions via AMPK activation (2016) (26)
DLX genes as targets of ALL‐1: DLX 2,3,4 down‐regulation in t(4;11) acute lymphoblastic leukemias (2003) (25)
Ki-67 Evaluation for Clinical Decision in Metastatic Lung Carcinoids: A Proof of Concept (2019) (25)
Natural and synthetic agents targeting inflammation and angiogenesis for chemoprevention of prostate cancer. (2008) (24)
Effect of osteoblast supernatants on cancer cell migration and invasion. (1995) (24)
Capecitabine in Breast Cancer: The Issue of Cardiotoxicity During Fluoropyrimidine Treatment (2010) (24)
The cAMP analog 8‐Cl‐cAMP inhibits growth and induces differentiation and apoptosis in retinoblastoma cells (1997) (24)
Pathologic Grading of Malignant Pleural Mesothelioma: An Evidence‐Based Proposal (2018) (24)
Diacylglycerol kinases are essential for hepatocyte growth factor‐dependent proliferation and motility of Kaposi’s sarcoma cells (2011) (23)
Natural Compounds of Marine Origin as Inducers of Immunogenic Cell Death (ICD): Potential Role for Cancer Interception and Therapy (2021) (23)
A highly invasive subpopulation of MDA-MB-231 breast cancer cells shows accelerated growth, differential chemoresistance, features of apocrine tumors and reduced tumorigenicity in vivo (2016) (23)
DNA damage induced by auramine O in liver, kidney, and bone marrow of rats and mice, and in a human cell line (alkaline elution assay and SCE induction). (1982) (23)
Invasive activity, spreading on and chemotactic response to laminin are properties of high but not low metastatic mouse osteosarcoma cells. (1991) (23)
Nonrandom chromosome changes in Kaposi sarcoma: cytogenetic and FISH results in a new cell line (KS-IMM) and literature review. (2001) (23)
Extracellular Matrix Invasion in Metastases and Angiogenesis: Commentary on the Matrigel "Chemoinvasion Assay". (2016) (23)
Interferons inhibit chemotaxis of transformed cells and their invasion of a reconstituted basement membrane. (1987) (22)
Endometrial Cancer Immune Escape Mechanisms: Let Us Learn From the Fetal–Maternal Interface (2020) (22)
The SARS-CoV-2 receptor, ACE-2, is expressed on many different cell types: implications for ACE-inhibitor- and angiotensin II receptor blocker-based antihypertensive therapies—reply (2020) (22)
Characterization of kaposis sarcoma-derived cell-cultures from an epidemic and a classic case. (1992) (22)
Anti-angiogenic properties of chemopreventive drugs: fenretinide as a prototype. (2009) (22)
Novel cell death pathways induced by N-(4-hydroxyphenyl)retinamide: therapeutic implications (2007) (22)
Fenretinide (4-HPR) Targets Caspase-9, ERK 1/2 and the Wnt3a/β-Catenin Pathway in Medulloblastoma Cells and Medulloblastoma Cell Spheroids (2016) (22)
Nutraceuticals and "Repurposed" Drugs of Phytochemical Origin in Prevention and Interception of Chronic Degenerative Diseases and Cancer. (2019) (22)
Inhibition of Angiogenesis by Type I Interferons in Models of Kaposi'S Sarcoma (1999) (22)
Isolation of spindle-shaped cell populations from primary cultures of Kaposi's sarcoma of different stage. (1996) (22)
Expression of functional tyrosine kinases on immortalized Kaposi's sarcoma cells (2000) (22)
Human chorionic gonadotropin inhibits Kaposi's sarcoma associated angiogenesis, matrix metalloprotease activity, and tumor growth. (2002) (21)
RB1 oncosuppressor gene over-expression inhibits tumor progression and induces melanogenesis in metastatic melanoma cells. (1996) (21)
Cancer stem cells and the tumor microenvironment: soloists or choral singers. (2011) (21)
Tumor and endothelial cell invasion of basement membranes (2008) (21)
Induction of apoptosis in Kaposi's sarcoma spindle cell cultures by the subunits of human chorionic gonadotropin. (1997) (21)
Generation of Expression Plasmids for Angiostatin, Endostatin and Timp-2 for Cancer Gene Therapy (1999) (21)
Preliminary Evidence on the Diagnostic and Molecular Role of Circulating Soluble EGFR in Non-Small Cell Lung Cancer (2015) (20)
In vitro Transformation of BALB/c 3T3 Cells by 1,1,2,2‐Tetrachloroethane (1990) (20)
Prophylaxis of non-communicable diseases: Why fruits and vegetables may be better chemopreventive agents than dietary supplements based on isolated phytochemicals? (2019) (19)
Hypomethylation of the interphotoreceptor retinoid-binding protein (IRBP) promotor and first exon is linked to expression of the gene. (1990) (19)
Invasiveness and chemotactic activity of oncogene transformed NIH/3T3 cells. (1990) (19)
Cell delivery of Met docking site peptides inhibit angiogenesis and vascular tumor growth (2010) (19)
Potentiation of the malignant phenotype of the undifferentiated ARO thyroid cell line by insertion of the bcl‐2 gene (1999) (18)
The expression of CD154 by Kaposi's sarcoma cells mediates the anti-apoptotic and migratory effects of HIV-1-TAT protein. (2006) (18)
Effect of a Purified Extract of Olive Mill Waste water on Endothelial CellProliferation, Apoptosis, Migration and Capillary-Like Structure in vitroand in vivo (2015) (18)
Antigenotoxic and Cancer Preventive Mechanisms of N-Acetyl-l-Cysteine (2004) (17)
Transcriptional control of cell density dependent regulation of matrix metalloproteinase and TIMP expression in breast cancer cell lines (2005) (17)
Transient modulation of cytoplasmic and nuclear retinoid receptors expression in differentiating human teratocarcinoma NT2 cells (2002) (17)
Angiostatin inhibits extracellular HIV-Tat-induced inflammatory angiogenesis. (2003) (17)
Progress towards gene therapy for cancer. (2000) (17)
Fluoropyrimidine toxicity in patients with dihydropyrimidine dehydrogenase splice site variant: the need for further revision of dose and schedule (2013) (17)
mRNA for interphotoreceptor retinoid-binding protein (IRBP): distribution and size diversity in vertebrate species. (1989) (16)
Acetyl-l-carnitine is an anti-angiogenic agent targeting the VEGFR2 and CXCR4 pathways. (2018) (16)
Diet and cancer. (1987) (16)
The tumor microenvironment: biology of a complex cellular and tissue society. (2010) (16)
Kaposis Sarcoma and Human Chorionic Gonadotropin: Mechanisms, Moieties and Mysteries (2002) (16)
Innate Immune Response Regulation by the Human RNASET2 Tumor Suppressor Gene (2019) (16)
Glycogen Synthase Kinase 3 Regulates Cell Death and Survival Signaling in Tumor Cells under Redox Stress1 (2014) (16)
Functional genomics of endothelial cells treated with anti-angiogenic or angiopreventive drugs (2010) (15)
Preliminary Evidence for IL-10-Induced ACE2 mRNA Expression in Lung-Derived and Endothelial Cells: Implications for SARS-Cov-2 ARDS Pathogenesis (2021) (15)
Decidual-Like NK Cell Polarization: From Cancer Killing to Cancer Nurturing. (2020) (14)
Pattern of collagen synthesis and chemotactic response of fibroblasts derived from mucopolysaccharidosis patients. (1984) (14)
The scaffold protein p140Cap limits ERBB2-mediated breast cancer progression interfering with Rac GTPase-controlled circuitries (2017) (14)
Angiopoietin2 and Tie2: Tied to Lymphangiogenesis and Lung Metastasis. New Perspectives in Antimetastatic Antiangiogenic Therapy (2012) (13)
Induction of a malignant phenotype in BALB/c 3t3 cells by 1,1,2,2-tetrachloroethane. (1993) (13)
Tumor microenvironment, a dangerous society leading to cancer metastasis. From mechanisms to therapy and prevention (2008) (13)
Thein vitro invasiveness and interactions with laminin of K-1735 melanoma cells. Evidence for different laminin-binding affinities in high and low metastatic variants (1989) (13)
Identification of immunodominant epitopes in inactivated Tat-vaccinated healthy and HIV-1-infected volunteers. (2003) (13)
Allele-specific patterns of the mouse parathyroid hormone-related protein: influences on cell adhesion and migration (2003) (12)
Antiangiogenic Activity of Chemopreventive Drugs (2003) (12)
A Subset of Large Cell Neuroendocrine Carcinomas in the Gastroenteropancreatic Tract May Evolve from Pre-existing Well-Differentiated Neuroendocrine Tumors (2021) (12)
Induction of apoptosis by fenretinide in tumor cell lines correlates with DLX2, DLX3 and DLX4 gene expression. (2003) (12)
SANIST: a rapid mass spectrometric SACI/ESI data acquisition and elaboration platform for verifying potential candidate biomarkers (2015) (12)
SANIST: optimization of a technology for compound identification based on the European Union directive with applications in forensic, pharmaceutical and food analyses. (2017) (11)
An Extract of Olive Mill Wastewater Downregulates Growth, Adhesion and Invasion Pathways in Lung Cancer Cells: Involvement of CXCR4 (2020) (11)
A PSA-guided approach for a better diagnosis of prostatic adenocarcinoma based on MALDI profiling and peptide identification. (2015) (11)
Rescuing COX-2 inhibitors from the waste bin. (2005) (11)
Induction of invasive and experimental metastasis potential in BALB/c 3T3 cells by benzo(a)pyrene transformation. (1992) (11)
The cAMP analog 8-Cl-cAMP inhibits growth and induces differentiation and apoptosis in retinoblastoma cells. (1997) (10)
Bringing new players into the field: onco-pharmacovigilance in the era of cardio-oncology (2012) (10)
The biological basis for antiangiogenic therapy. (2000) (10)
Dermatofibrosarcoma protuberans: altered collagen metabolism in cell culture. (1985) (10)
MMP-9 and IL-1β as Targets for Diatoxanthin and Related Microalgal Pigments: Potential Chemopreventive and Photoprotective Agents (2021) (10)
Effect of HGF-like basic hexapeptides on angiogenesis. (2001) (10)
HIV-1 tat acts as a growth factor and induces angiogenic activity in BK virus/tat transgenic mice. (1994) (10)
Angiogenesis at the Interface between Basic and Clinical Research (1999) (10)
Renal dysfunction and increased risk of cardiotoxicity with trastuzumab therapy: a new challenge in cardio-oncology (2012) (10)
Serum Steroid Ratio Profiles in Prostate Cancer: A New Diagnostic Tool Toward a Personalized Medicine Approach (2018) (9)
The Angiogenic Switch in Solid Tumors: Clinical Implications (2002) (9)
A method to select cell populations with enhanced chemotatic activity (1984) (9)
In vitro and in vivo tumor growth inhibition by a p16‐mimicking peptide in p16INK4A‐defective, pRb‐positive human melanoma cells (2005) (9)
Cardiovascular Active Peptides of Marine Origin with ACE Inhibitory Activities: Potential Role as Anti-Hypertensive Drugs and in Prevention of SARS-CoV-2 Infection (2020) (9)
Anti-FGF 2 approaches as a strategy to compensate resistance to anti-VEGF therapy : long-pentraxin 3 as a novel antiangiogenic FGF 2-antagonist (2009) (9)
TIMP1 and TIMP2 Downregulate TGFβ Induced Decidual-like Phenotype in Natural Killer Cells (2021) (9)
Biomarkers of cancer angioprevention for clinical studies (2015) (8)
Distinct chemotactic and angiogenic activities of peptides derived from Kaposi's sarcoma virus encoded chemokines. (2000) (8)
Surface-activated chemical ionization-electrospray ionization source improves biomarker discovery with mass spectrometry. (2012) (8)
Structure, Expression and Function of Mouse Laminin (1987) (8)
A Polyphenol-Rich Extract of Olive Mill Wastewater Enhances Cancer Chemotherapy Effects, While Mitigating Cardiac Toxicity (2021) (8)
Factors regulating basement membrane invasion by tumor cells. (1988) (8)
Retinoic acid negatively regulates β4 integrin expression and suppresses the malignant phenotype in a Lewis lung carcinoma cell line (2005) (8)
New take on comparative immunology: relevance to immunotherapy. (2009) (8)
Alteration of laminin production in small-cell lung carcinoma: possible correlation with the absence of the basement membrane. (1993) (7)
The urokinase-type plasminogen activator, its receptor and u-PA inhibitor type-1 affect in vitro growth and invasion of Kaposi's sarcoma and capillary endothelial cells: role of HIV-Tat protein. (2005) (7)
Comparison of the Chemotactic Response to Conditioned Medium of Balb/c3T3 Fibroblasts and their SV 40 Transformants (1985) (7)
Speckle-Tracking Echocardiography for Cardioncological Evaluation in Bevacizumab-Treated Colorectal Cancer Patients (2020) (7)
Re: Microarray studies challenge theories of metastasis. (2003) (7)
Inhibition of a vascular ocular tumor growth by IL-12 gene transfer (2007) (7)
A new tumor suppressor gene: invasion, metastasis, and angiogenesis as potential key targets. (2006) (7)
Case Report: An Unusual Case of Biventricular Thrombosis in a COVID-19 Patient With Ischemic Dilated Cardiomyopathy: Assessment of Mass Mobility and Embolic Risk by Tissue Doppler Imaging (2021) (7)
Polarization of Tumor Infiltrating Leukocytes from Innate Immunity and their role in the Pro-angiogenic Phenotype in NSCLC (2015) (6)
Two Novel Ceramide-Like Molecules and miR-5100 Levels as Biomarkers Improve Prediction of Prostate Cancer in Gray-Zone PSA (2021) (5)
"In vitro" models for studying the malignant phenotype: chemotaxis and chemoinvasion. (1988) (5)
Induction of chemotactic and invasive phenotype in BALB/c 3T3 cells by 1,2-dibromoethane transformation. (1993) (5)
Assessment of angiogenic potential--the use of AIDS-KS cell supernatants as an in vitro model. (1992) (5)
Effects of Diet-Derived Molecules on the Tumor Microenvironment (2012) (4)
Unsung Hero Robert C. Gallo (2009) (4)
Modulation of y-79 retinoblastoma cell-differentiation and IRBP expression by dibutyryl-cyclic-amp and laminin. (1993) (4)
Analysis of K-ras, p53, bcl-2 and Rb expression in non-small cell lung cancer cell lines. (1997) (4)
Inhibition of malignant tumor cell invasion: an approach to anti-progression. (1993) (4)
Models of inflammatory processes in cancer (2006) (3)
Mechanisms of kaposis-sarcoma cell supernatant-induced vascular cell invasion. (1995) (3)
Hyperforin blocks neutrophil activation of MMP-9, motility and recruitment,and restrains inflammation-triggered angiogenesis and lung fibrosis (2007) (3)
Standard operating procedures for biobank in oncology (2022) (3)
Abstract 5214: Synergistic activity of aspirin, atenolol and metformin in the inhibition of angiogenesis, local and metastatic growth of breast cancer by targeting both neoplastic and microenvironment cells (2015) (3)
The fibroblastic nature of dermatofibrosarcoma protuberans: Morphological investigations in vivo and in vitro (2004) (3)
The Microalgal Diatoxanthin Inflects the Cytokine Storm in SARS-CoV-2 Stimulated ACE2 Overexpressing Lung Cells (2022) (3)
Basement membranes, reconstituted to assess the invasiveness of tumor cells (1988) (3)
Erratum: TIMP-2, over-expression reduces invasion and angiogenesis and protects B16F10 melanoma cells from apoptosis (International Journal of Cancer (1998) 75 (246-253)) (1999) (3)
Expression of mRNA for gelatinase A and TIMP-2 in cell cultures and tissue samples derived from breast and lung carcinomas. (1996) (3)
Endothelial Growth Factor-A Mediated by Neutrophil-Derived Vascular Protein-2-Induced Angiogenesis In Vivo Is CXCL1/Macrophage Inflammatory (2004) (3)
The Angiogenic Switch: Role of Immune Cells (2011) (3)
Surface-activated chemical ionization-electrospray mass spectrometry in the analysis of urinary thiodiglycolic acid. (2013) (3)
Charlson comorbidity index, neutrophil-to-lymphocyte ratio and undertreatment with renin-angiotensin-aldosterone system inhibitors predict in-hospital mortality of hospitalized COVID-19 patients during the omicron dominant period (2022) (3)
Chemotactic activity "in vitro" and transplantability in isogenic mice of radionuclide-induced murine osteosarcomas. (1987) (2)
Choking hypoxia-inducible factor 1alpha: a novel mechanism for connective tissue growth factor inhibition of angiogenesis. (2006) (2)
Chemotactic response of SV40 virus transformed fibroblasts to conditioned medium: dependence on time and cell number. (1984) (2)
VEGF Receptor 1 contributes to resistance to anti-EGFR drugs in human cancer cells. (2008) (2)
High Chemotactic Motility and Growth in Hard Agar of a Variant of RSV-Transformed Fibroblasts are Lost in Late Passages (1988) (2)
Proffered abstracts from the 17th Biennial Congress of the Metastasis Research Society (2018) (2)
In Vitro Evaluation of Antioxidant Potential of the Invasive Seagrass Halophila stipulacea (2021) (2)
Editorial: Immunotherapy as an Evolving Approach for the Treatment of Breast Cancer (2021) (2)
Evidence of Endocrine-Immunological Cross-Talk Oxytocin Is a Growth Factor for Kaposi ' s Sarcoma Cells : Updated (2002) (2)
Regulation of angiogenesis by angiostatin through immune cells and IL 12 production (2006) (2)
A WT1 expressing metastatic human kaposi sarcoma xenograft model (2008) (2)
Overcoming Resistance to Checkpoint Inhibitors: Natural Killer Cells in Non-Small Cell Lung Cancer (2022) (2)
An Olive Oil Mill Wastewater Extract Improves Chemotherapeutic Activity Against Breast Cancer Cells While Protecting From Cardiotoxicity (2022) (2)
Molecular genetics of interphotoreceptor retinoid-binding protein (1988) (2)
PKHhigh/CD133+/CD24− Renal Stem-Like Cells Isolated from Human Nephrospheres Exhibit In Vitro Multipotency (2020) (2)
Oncosuppressor genes: mechanisms of inactivation for the retinoblastoma gene and p53. (1993) (2)
Anti-KS activity still a mystery (1998) (2)
Altered production of laminin and nidogen by high and low metastatic variants of murine melanoma cells. (1996) (2)
Response: Re: Neurocognitive Functioning in Adult Survivors of Childhood Noncentral Nervous System Cancers (2011) (2)
Invasion and Metastasis (2010) (2)
Abstract 5272: Chemopreventive activities of a polyphenol rich purified extract from olive oil processing on colon cancer cells (2017) (1)
Abstract LT006: NK cells from prostate cancer patients acquire a pro-angiogenic phenotype and polarize macrophages towards a M2-like/TAM subset (2021) (1)
Clinical implications of lung neuroendocrine neoplasm classification (2020) (1)
Evaluation of the immunomodulatory effects of interleukin-10 on peripheral blood immune cells of COVID-19 patients: Implication for COVID-19 therapy (2022) (1)
The Carotenoid Diatoxanthin Modulates Inflammatory and Angiogenesis Pathways In Vitro in Prostate Cancer Cells (2023) (1)
Neutrophils3 by Activated Human - Kringle 1 Generation of Biologically Active Angiostatin (2002) (1)
Author Correction: The scaffold protein p140Cap limits ERBB2-mediated breast cancer progression interfering with Rac GTPase-controlled circuitries (2018) (1)
Prostate Cancer and the Invasive Phenotype: New In Vivo and In Vitro Approaches (1988) (1)
Regulation of invasiveness of human breast cancer cell lines in vitro. (1988) (1)
AACR Calls on Congress to Take Immediate Action Against COVID-19 and Protect Patients with Cancer During the Pandemic. (2020) (1)
Abstract 5086: Acetyl-L-carnitine (ALCAR) inhibits angiogenesis, migration and macrophage recruitment in prostatic cancer cells (2019) (1)
Abstract 562: Stromal TLR4 and IL 6 expression as potential prognostic inflammation-associated markers for colo-rectal cancer progression (2010) (1)
What the oncologist can learn from diabetes studies: Epidemiology, prevention, management, cure. (2018) (1)
Kaposi's Sarcoma and HIV-Tat: Challenges to Antiangiogenesis Research (2005) (1)
Vicia villosa agglutinin (lectin)-binding carbohydrate(s) is expressed in atypical MUC1, serotransferrin and immunoglobulin of rat ascites hepatoma AH109A cells with lymphatic metastasis propensity. (2005) (1)
Growth of cells from esophageal squamous cell carcinoma biopsies in a reconstituted basement membrane. (1989) (1)
Angioprevention: Targeting angiogenesis and inflammation in prevention strategies (2007) (1)
Effect of different cell detachment techniques on fibroblast chemotaxis to fibronectin and conditioned medium. (1986) (1)
This information is current as Angiogenesis , and Pulmonary Fibrosis Inhibition of Inflammation , Associated Neutrophil Restraint by Green Tea : Spiridione Garbisa (2003) (1)
[Heart failure in women treated with adjuvant trastuzumab for breast cancer]. (2012) (1)
Relationship between DNA ploidy, cytological grade of malignancy and in vitro invasiveness for human sarcomas (1991) (1)
[Standardization of a method of determining the thiolic-SH groups in human blood due to kinetic considerations]. (1980) (1)
Rexinoid LG100268 affects angiogenesis in vitro and in vivo (2007) (0)
Angiogenesis as a key target of cancer prevention: The effect of the CDDO-Me triterpenoid (2007) (0)
Abstract 5262: Chemopreventive and angiopreventive activity of a purified polyphenol-rich extract from olive mill wastewaters (2016) (0)
Abstract 2328: Targeting angiogenesis: Anti-docking site peptides to Met receptor and nanotechnology (2012) (0)
[Chemotactic activity of fibroblasts in mucopolysaccharidoses]. (1983) (0)
Hyperforin is a potent inhibitor of inflammation-triggered angiogenesis (2007) (0)
Abstract 121: Angiogenin and the mmp9-timp2 axis are strongly upregulated in pro-angigoenic dnk-like cells isolated from colorectal cancer patients (2018) (0)
A polyphenol-rich extract from olive-mill waste waters targets the IL-6/STAT3 pathway in prostate cancer cell lines (2018) (0)
Inhibition of Inflammation, Associated Neutrophil Restraint by Green Tea: (2003) (0)
Tumor infiltrating (TINKs) and tumor associated (TANKs) from colorectal cancer patients are proangiogenic and express angiogenin and the MMP9-TIMP2, similar to decidual NK cells (2018) (0)
Thanks to Reviewers (2014) (0)
Abstract 5303: The role of the anti-hyperglycemic drug metformin in regulating tumor angiogenesis (2012) (0)
8 -CI-cAMP induction of differentiation and apoptosis in Y-79 human retinoblastoma cell line (1997) (0)
Immuno-Angioprevention by IL-12 gene transfer (2004) (0)
Anti-KS activity still a mystery [3] (multiple letters) (1998) (0)
Optimisation and Efficiency in Cancer Care (2021) (0)
S13. Angiopreventive properties of diet derivatives (2008) (0)
Abstract 4652: Wide antiproliferative and proapoptotic activity of the natural prenyl-flavonoid Xanthohumol and its derivatives on cancer cells, peripheral blood mononuclear cells, and human primary endothelial cells (2015) (0)
Abstract 18: The CXCR4/CXCL12 axis is a target of a polyphenol extract from olive oil processing with potential cancer prevention and interception activities (2020) (0)
Abstract A23: Metformin as a potent antiangiogenic factor: From diabetes to cancer angioprevention (2013) (0)
EFFECTS OF 8-CI-cAMP ON CELL GROWTH, DIFFERENTIATION AND APOPTOSIS IN Y-79 RETINOBLASTOMA CELL LINE (1996) (0)
660 Phenformin targets the stem cell compartment in melanoma (2016) (0)
The role of tumor infiltrating and tumor associated natural killer cells in promotion of angiogenesis in colorectal cancer patients (2015) (0)
337 Invasiveness of endothelial cells: Role in tumor associated angiogenesis (1995) (0)
Acetyl-L-Carnitine downregulates invasion (CXCR4/CXCL12, MMP-9) and angiogenesis (VEGF, CXCL8) pathways in prostate cancer cells: rationale for prevention and interception strategies (2019) (0)
PKHhigh/CD133+/CD24- stem-like cells isolated from human nephrospheres can be committed to endothelial phoenotype (2018) (0)
Vascular Endothelial Growth Factor Receptor-1 Contributes to Resistance toAnti ^ Epidermal Growth Factor Receptor Drugs in Human Cancer Cells (2008) (0)
116 Detection of Circulating Tumour Cells on the Basis of Cytomorphology, Immunofluorescence and in Situ Hybridization with the Aid of a “Robotized Microscope”: from Bench to Bedside (2012) (0)
Abstract 3843: TIMP1 and TIMP2 re-educate TGFβ induced pro-inflammatory/pro angiogenic decidual-like NK cells phenotype (2022) (0)
P32 The role of the anti-hyperglycemic metformin, a potential chemopreventive agent, in regulating tumour angiogenesis (2010) (0)
OC-01 Inhibition of anti-angiogenesis cardiovascular events and chemotherapy cardiotoxicity by angioprevention agents (2007) (0)
18 INVITED Angiogenesis as a target for chemoprevention (2006) (0)
Generation of angiostatin expression vectors for antiangiogenic gene therapy of Kaposi sarcoma (1999) (0)
Natural killer cells from patients with either malignant or inflammatory pleural effusions display decreased cytotoxic capacity and decidual-like phenotype (2016) (0)
Abstract 5251: Skeletonema marinoi algae extract and carotenoid fucoxanthin are endowed with potential chemopreventive and angiopreventive properties for prostate cancer (2023) (0)
326 Targets of “angioprevention”: from inflammatory angiogenesis to hypoxia (2010) (0)
This information is current as 3 by Activated Human Neutrophils − Kringle 1 Generation of Biologically Active Angiostatin (2002) (0)
NK cells as modulators of tumor angiogenesis (2010) (0)
A Case of Acute Pericarditis After COVID-19 Vaccination (2021) (0)
Abstract A24: Endothelial cell aging and possible role in angioprevention: increased expression of TGFβ and other antiangiogenic factors (2008) (0)
Molecular Pathways for CancerAngioprevention (2007) (0)
Skeletonema marinoi Extracts and Associated Carotenoid Fucoxanthin Downregulate Pro-Angiogenic Mediators on Prostate Cancer and Endothelial Cells (2023) (0)
Natural killer cells from malignant pleural effusion show a decidual-like phenotype and an alternative activatory state. (2018) (0)
30Extracellular vesicles in systemic sclerosis as potential mediator for pulmonary vascular disease (2018) (0)
Natural killer cells from pleural effusions are responsive to interleukin-2 but are endowed with a potent pro-angiogenic feature (2014) (0)
Late abstracts 186–187 (2005) (0)
Changeable chemotactic response of metastatic variant lines of RSV-transformed mouse fibroblasts (1986) (0)
Abstract 1010: Paradoxic effects of metformin on endothelial cells and angiogenesis (2014) (0)
Abstract 3244: Tumor infiltrating (TINKs) and tumor-associated (TANKs) natural killer cells (TINKs): A new paradigm in colorectal cancer (2016) (0)
Speckle-Tracking Echocardiography for Cardioncological Evaluation in Bevacizumab-Treated Colorectal Cancer Patients (2020) (0)
Molecular mechanisms of HIV-associated Kaposi's sarcoma (1999) (0)
Studies on retinoblastoma cell differentiation using a photoreceptor specific gene (1993) (0)
Meeting Report The biological basis for antiangiogenic therapy (2000) (0)
Abstract 3159: Targeting the TGFΒ/TIMP-1/2 axes to re-educate pro-inflammatory/pro angiogenic NK cells in cancer patients (2021) (0)
The pro-angiogenic phenotype and functions of colorectal cancer tumour infiltrating (TINKs) and tumour associated (TANKs) natural killer cells (2016) (0)
The Role of Neutrophils in Tumor Angiogenesis (2005) (0)
Circulating natural killer cells in patients with symptomatic atherosclerosis acquire the CD9+CD49A pro-inflammatory phenotype and support M1-like macrophage polarization (2022) (0)
Presence of “KSHV” (Kaposi's sarcoma associated herpes-like virus) in the biopsy of a sporadic HIV-negative KS patient, but not in cells cultured from a KS biopsy of the same patient (2007) (0)
Inhibition of breast cancer derived cell invasion by suramin in vitro (1991) (0)
Natural killer cells from patients with malignant or inflammatory pleural effusions display decreased cytotoxicity and a decidual NK-like phenotype (2016) (0)
P33 Chemopreventive strategies for cardiotoxicity induced by anticancer drugs (2010) (0)
Abstract 1581: Prostate tumor associated NK cells (PTANKs) acquire the decidual-like/pro-angiogenic phenotype and polarize macrophages towards the M2-like/TAM subset (2020) (0)
Inflammatory angiogenesis: A target for chemoprevention. (2006) (0)
The chemopreventive polyphenol curcumin inhibits matrix metalloproteinase expression and invasion via an NF κB-independent pathway (2007) (0)
Tumour infiltrating (TINK) and Tumour associated (TANK) natural killer cells: novel inflammatory orchestrators in colorectal cancer (CRC) progression and angiogenesis (2017) (0)
Functional Genomics Of Endothelial Cells Treated With Chemopreventive Anti‐Angiogenic Drugs (2012) (0)
Pleural effusion NK cells from metastatic tumors display pro-angiogenic features and pleural effusion fluids block their response to IL-2 treatment (2017) (0)
Glycogen Synthase Kinase 3 Regulates Cell Death and Survival Signaling in Tumor Cells under (2014) (0)
Co-targeting triple-negative breast cancer cells and endothelial cells by metronomic chemotherapy inhibits cell regrowth and migration via downregulation of the FAK/VEGFR2/VEGF axis and autophagy/apoptosis activation (2022) (0)
Tumour infiltrating (TINKs) and tumour associated (TANKs) natural killer cells: a new paradigm in colorectal cancer angiogenesis (2016) (0)
Cancer Prevention Prioritized at AACR Annual Meeting and a New Working Group. (2022) (0)
Peptide anti-angiogenique (2005) (0)
Expression and tissue specificity of a retinoid binding protein (1990) (0)
New Insights on the Multiple Effects of Green Tea Polyphenol Epigallocate Chin-3-gallate (Egcg) in Tumor Prevention and Therapy (2001) (0)
Prostate cancer associated natural killer cells show a pro-angiogenic and pro-inflammatory phenotype. (2020) (0)
Validation of proposed prostate cancer biomarkers with gene expression data: a long road to travel (2014) (0)
Genomics of metastatic progression (2010) (0)
Synthetic analogs of xanthohumol for use in the prevention and/or treatment of tumors (2014) (0)
Erratum: In vitro models of angiogenesis: The use of Matrigel (The International Journal of Biological Markers (1999) 14, 4 (243-246)) (2000) (0)
Relationship between levels of HER-2 amplification and pathologic complete response to trastuzumab-based neoadjuvant treatment. (2015) (0)
Erratum: Angiogenesis at the interface between basic and clinical research (The International Journal of Biological Markers (1999) 14, 4 (202-206)) (2000) (0)
Inflammatory angiogenesis as a target for prevention and therapy: Kaposi's sarcoma and HIV tat as models (2006) (0)
Microphotometric and morphometric evaluation by image analysis of human Y79 retinoblastoma cells over time in culture (1996) (0)
H26EGFR-related miRNAs as potential biomarkers of response to Erlotinib in metastatic NSCLC patients (2015) (0)
COLD-PCR protocols to enrich KRAS codon 61 and 146 mutations in heterogeneous tumor samples. (2014) (0)
Migration of y 79 retinoblastoma cells to a basement membrane extract and to purified lamin ln (1988) (0)
The chemopreventive polyphenol curcumin down-regulates the expression of inflammatory cytokines CXCL1 and -2 in MDA-MB-231 breast cancer cells (2007) (0)
VEGFR2 and CXCR4 pathways are modulated by acetyl-l-Carnitine that acts as an anti-angiogenic agent (2018) (0)
Malignant: Insights into the process of metastasis and how we can stop it (2021) (0)
Angiogenesis and inflammation as target for cancer prevention (2015) (0)
28th meeting of the Italian Cancer Society (SIC). New challenges of molecular oncology. (2002) (0)
Abstract 2367: Tumor-infiltrating (TINKs) and tumor-associated (TANKs) natural killer cells: a new player in the inflammatory orchestration of tumor angiogenesis in colon cancer (2015) (0)
Issue Information (2018) (0)
F1 Cancer Stem Cell Features in Subpopulations Isolated From Kaposiʼs Sarcoma Cell Cultures (2012) (0)
Modulation of photoreceptor and neural marker expression by cAMP and laminin in retinoblastoma cells (1993) (0)
Abstract A33: Expression of markers of inflammation and angiogenesis in preneoplastic lesions and colon cancer progression (2010) (0)
[Somatostatinergic control of Kaposi's sarcoma growth through the inhibition of angiogenesis]. (2001) (0)
77 Proffered Paper: The Pro-angiogenic Phenotype of Natural Killer Cells Infiltrating Squamous Cell Carcinoma Lung Cancer (2012) (0)
A36Relationship between levels of HER-2 amplification and pathologic complete response to trastuzumab-based neoadjuvant treatment (2015) (0)
Proceedings of the SSOSB Residential Course on Angiogenesis Inhibitors: Pharmacology and Potential Therapeutic Applications, Siracusa, Italy, 7-8 May 1999: Introduction (1999) (0)
Erratum: Inhibition of angiogenesis by type I interferons in models of Kaposi's sarcoma (The International Journal of Biological Markers (1999) 14, 4 (257-262)) (2000) (0)
Invasion of a reconstituted basement membrane by tumor cells and its modulation (1991) (0)
ANGIOGENIC AND PROTEASE INDUCING ACTIVITIES OF HIV-1 TAT PROTEIN FROM BKV/TAT TRANSGENIC MICE (1995) (0)
Author Index (2008) (0)
Abstract 4044: An extract of olive oil wastewater enhances chemotherapy effects on breast cancer cells without exacerbating cardiovascular toxicity (2022) (0)
Abstract B105: Inhibition of angiogenesis by oleanoleic acid-derived triterpenoids: mechanisms of action and potential prostate cancer prevention (2008) (0)
SV40 transformed fibroblasts recognize the same 140 kD fibronectin chemotactic fragment as non-transformed cells (1985) (0)
Simultaneous induction of transformed, invasive and metastatic phenotype in BALB/c 3T3 cells by 1,1,2,2-tetrachloroethane (1991) (0)
Most high-grade neuroendocrine tumours of the lung develop secondarily from preexisting carcinoids: Unexpected findings skipping the current pathogenesis paradigm (2018) (0)
Response to the Letter to the Editor (2011) (0)
The Pharmacologist’s Point of View: Mechanisms of Cardiotoxicity (2017) (0)
Short Communication Endothelin Receptor Blockade Inhibits Proliferation of Kaposi’s Sarcoma Cells (2001) (0)
STAT3 and STAT5 drive the pro-angiogenic NK cell polarization in colorectal cancer patients (2017) (0)
365 Cell delivery of the Met docking site peptide inhibits angiogenesis and vascular tumour growth (2010) (0)
Kaposi's sarcoma, vascular permeability, and scientific integrity. (1994) (0)
DNA Fragmentation and Sister Chromatid Exchanges Induced by Commercial Auramine O, Purified Auramine, and Michler’s Ketone (1983) (0)
25 Molecular mechanisms of angiogenesis associated to kaposi's sarcoma (1995) (0)
Release And Angiogenic Properties Of Extracellular Hiv-1 Tat Protein (1993) (0)
TYPE IV COLLAGENASE AND TIMP-2 MRNA EXPRESSION IN BREAST AND LUNG CARCINOMA SPECIMENS (1995) (0)
Y-79 retinoblastoma cells differentiate in the presence of laminin but lack “classic” laminin receptors (1992) (0)
Abstract 2303: Innate immunity driving tumor angiogenesis: the role of natural killer cells in non small cell lung cancer (NSCLC) . (2013) (0)
ASSAY FOR QUANTITATING INVASIVENESS OF TUMOR CELLS Invasion Chamber Matrix Barrier Filter Underside : Non-Invasive Cells Filter Underside : Invasive Cells (2006) (0)
Dietary products and angiogenesis. (2007) (0)
Abstract 1605: Extracellular vesicles from metastatic non-small cell lung cancer induce the angiogenic switch in natural killer cells (2020) (0)
Erratum: Generation of Expression plasmids for angiostatin, endostatin and TIMP-2 for cancer gene therapy (The International Journal of Biological Markers (1999) 14, 4 (251-256)) (2000) (0)
Interferons as potential therapeutic agents for AIDS-associated KS (2007) (0)
Natural killer cells from malignant pleural effusions show a decidual-like, pro-angiogenic phenotype (2015) (0)
Triterpenoids affect angiogenesis and prevent neoplastic progression (2008) (0)
Testing the Halophila Stipulacea Environmental Threat as A Potential Antioxidant Agent (2020) (0)
The development of new blood and lymphatic vessels from preex- (2012) (0)
Angiogenesis success and pitfalls in diagnosis, therapy and cancer prevention (2010) (0)
Tumour Infiltrating ( TINK ) and Tumour Associated ( TANK ) Natural Killer cells : role in colorectal cancer ( CRC ) progression and angiogenesis (2016) (0)
Abstract B76: Synthetic triterpenoids as candidate drugs for cancer prevention and treatment (2011) (0)
NEWS TO THE EDITOR (1999) (0)
Rationale, Problems and Perspectives in Anti-angiogenic Therapy (2001) (0)
Overview of the SSOSB Course “Inhibitors of Angiogenesis: Pharmacology and Therapeutic Potential” (1999) (0)
Abstract 3272: A Met receptor docking site peptide fused to cell-penetrating sequences acts as a powerful inhibitor of angiogenesis and vascular tumour growth (2011) (0)
Natural killer cells from malignant pleural effusion are switched toward an NK proangiogenic polarization (2018) (0)

This paper list is powered by the following services:

Other Resources About Adriana Albini

en.wikipedia.org

What Schools Are Affiliated With Adriana Albini?

Adriana Albini is affiliated with the following schools:

Adriana Albini's Academic­Influence.com Rankings

Adriana Albini's Degrees

Why Is Adriana Albini Influential?

Adriana Albini's Published Works

Published Works

Other Resources About Adriana Albini

What Schools Are Affiliated With Adriana Albini?

Adriana Albini's AcademicInfluence.com Rankings